Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-6362
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Mass spectrometry-based proteomics identify novel serum osteoarthritis biomarkers ; volume:24 ; number:1 ; day:23 ; month:5 ; year:2022 ; pages:1-16 ; date:12.2022
Arthritis Research & Therapy ; 24, Heft 1 (23.5.2022), 1-16, 12.2022
- Creator
-
Tardif, Ginette
Paré, Frédéric
Gotti, Clarisse
Roux-Dalvai, Florence
Droit, Arnaud
Zhai, Guangju
Sun, Guang
Fahmi, Hassan
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13075-022-02801-1
- URN
-
urn:nbn:de:101:1-2022072619273574998969
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Tardif, Ginette
- Paré, Frédéric
- Gotti, Clarisse
- Roux-Dalvai, Florence
- Droit, Arnaud
- Zhai, Guangju
- Sun, Guang
- Fahmi, Hassan
- Pelletier, Jean-Pierre
- Martel-Pelletier, Johanne
- SpringerLink (Online service)
Other Objects (12)
Computational approaches to enhance mass spectrometry-based proteomics
Computational approaches to enhance mass spectrometry-based proteomics
Proteome discovery pipeline for mass spectrometry-based proteomics
Data acquisition methods for next-generation mass spectrometry-based proteomics
Mass spectrometry-based quantitative proteomics to investigate RNA-protein interactions
Modified cysteine S-phosphopeptide standards for mass spectrometry-based proteomics
Mass spectrometry-based proteomics: from deep proteomes to clinical application
Temporal analysis of parkin-dependent mitophagy using mass spectrometry-based proteomics
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
Current challenges in software solutions for mass spectrometry-based quantitative proteomics
Molecular mechanisms of fragile X syndrome investigated by mass spectrometry-based proteomics
Computational approaches to enhance mass spectrometry-based proteomics
Computational approaches to enhance mass spectrometry-based proteomics
Proteome discovery pipeline for mass spectrometry-based proteomics
Data acquisition methods for next-generation mass spectrometry-based proteomics
Mass spectrometry-based quantitative proteomics to investigate RNA-protein interactions
Modified cysteine S-phosphopeptide standards for mass spectrometry-based proteomics
Mass spectrometry-based proteomics: from deep proteomes to clinical application
Temporal analysis of parkin-dependent mitophagy using mass spectrometry-based proteomics
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
Current challenges in software solutions for mass spectrometry-based quantitative proteomics
Molecular mechanisms of fragile X syndrome investigated by mass spectrometry-based proteomics
Computational approaches to enhance mass spectrometry-based proteomics
Computational approaches to enhance mass spectrometry-based proteomics
Proteome discovery pipeline for mass spectrometry-based proteomics
Data acquisition methods for next-generation mass spectrometry-based proteomics
Mass spectrometry-based quantitative proteomics to investigate RNA-protein interactions
Modified cysteine S-phosphopeptide standards for mass spectrometry-based proteomics
Mass spectrometry-based proteomics: from deep proteomes to clinical application
Temporal analysis of parkin-dependent mitophagy using mass spectrometry-based proteomics
Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
Urinary biomarker discovery in gliomas using mass spectrometry-based clinical proteomics
Current challenges in software solutions for mass spectrometry-based quantitative proteomics